Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Xinqun Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5043084593. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 14

  1. Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarci… Co-author DOI 10.1038/s41418-024-01387-2↗
  2. Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-1527↗
  3. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci151604↗
  4. Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Co-author DOI 10.1038/s41419-021-03970-8↗
  5. Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. First author DOI 10.1158/2159-8290.cd-20-1228↗
  6. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. Co-author DOI 10.1172/jci.insight.146133↗
  7. Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. Co-author DOI 10.1016/j.sopen.2019.05.004↗
  8. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-018-0207-3↗
  9. Hypoxia-Induced Autophagy Degrades Stromal Lumican into Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma: A Mini-Review. First author DOI 10.29245/2578-2967/2019/1.1165↗
  10. Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarci… Co-author DOI 10.1158/1535-7163.mct-16-0526↗
  11. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Co-author DOI 10.1158/1078-0432.ccr-15-2780↗
  12. Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-15-2936↗
  13. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Co-author DOI 10.1158/1078-0432.ccr-14-0970↗
  14. Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Co-author PMID 25202045↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason B. Fleming · 14 shared papers, 2014–2024 · strength 1.51
  2. Ya’an Kang · 13 shared papers, 2014–2024 · strength 1.35
  3. Bingbing Dai · 9 shared papers, 2016–2024 · strength 0.94
  4. Mayrim V. Rios Perez · 7 shared papers, 2016–2024 · strength 0.81
  5. Michael P. Kim · 6 shared papers, 2019–2024 · strength 0.75
  6. David Roife · 8 shared papers, 2014–2024 · strength 0.72
  7. Eugene Jon Koay · 6 shared papers, 2016–2024 · strength 0.68
  8. Rolf A. Brekken · 4 shared papers, 2017–2024 · strength 0.49
  9. Jenying Deng · 4 shared papers, 2021–2022 · strength 0.45
  10. Yeon‐Ju Lee · 3 shared papers, 2016–2024 · strength 0.35
  11. Matthew H. G. Katz · 4 shared papers, 2014–2022 · strength 0.32
  12. Anirban Maitra · 2 shared papers, 2021–2022 · strength 0.21
  13. Florencia M. McAllister · 2 shared papers, 2021–2022 · strength 0.21
  14. Huamin Wang · 3 shared papers, 2014–2022 · strength 0.20
  15. Bhaswati Sarcar · 1 shared paper, 2019 · strength 0.16
  16. Jianhua Ling · 2 shared papers, 2016–2022 · strength 0.16
  17. Paul J. Chiao · 2 shared papers, 2016–2022 · strength 0.16
  18. Huocong Huang · 1 shared paper, 2021 · strength 0.12
  19. Jeffrey H. Lee · 1 shared paper, 2022 · strength 0.11
  20. Robert A. Wolff · 1 shared paper, 2022 · strength 0.11
  21. Naruhiko Ikoma · 1 shared paper, 2022 · strength 0.11
  22. Ronald Anthony Depinho · 1 shared paper, 2022 · strength 0.11
  23. Manoop S. Bhutani · 1 shared paper, 2022 · strength 0.11
  24. Jeffrey E. Lee · 1 shared paper, 2022 · strength 0.11
  25. Brian R. Weston · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.